Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer

NCT03503344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Castration Levels of Testosterone
Castration-Resistant Prostate Carcinoma
PSA Progression
Stage IV Prostate Adenocarcinoma AJCC v7

Interventions

DRUG: Apalutamide
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

University of California, San Francisco

Collaborators

[object Object]